On a different note, in ER+ BC cells endocrine therapy may exert a paradoxical effect on the GDNF/RET axis, increasing RET expression at both the RNA and protein level, a mechanism that seemingly relies on pro-inflammatory mediators (24, 41). This evidence concerns the gene GDNF and breast cancer.